Gengpeng Lin
Zhongshan Road
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Novel NOTCH2-NTRK1 fusion confers osimertinib resistance in EGFR-mutant non-small cell lung cancer by interacting with EGFR.
Journal: Translational oncology
Published: July 19, 2025
Biomarker and Prognostic Value of Super-ARMS Detection for EGFR Mutation in Advanced NSCLC.
Journal: OncoTargets and therapy
Published: January 22, 2025
A Novel Oncogenic and Drug-Sensitive KIF5B-NTRK1 Fusion in Lung Adenocarcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: September 02, 2024
Identification and Application of a Novel Immune-Related lncRNA Signature on the Prognosis and Immunotherapy for Lung Adenocarcinoma.
Journal: Diagnostics (Basel, Switzerland)
Published: September 20, 2022
Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report.
Journal: Frontiers in oncology
Published: April 06, 2022
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
Journal: Frontiers in genetics
Published: February 20, 2022
The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
Journal: Frontiers in genetics
Published: August 23, 2021
Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: April 21, 2021
Low prognostic nutrition index predicts poorer quality of life in late-stage lung cancer.
Journal: Annals of palliative medicine
Published: August 26, 2020
Last Updated: 09/26/2026